Japan Medical Cannabis Market Overview

Market Statistics

Base Year: 2024
Historical Years: 2019-2024
Forecast Years: 2025-2033
Market Size in 2024: USD 2,188.2 Million
Market Forecast in 2033: USD 4,070.6 Million
Market Growth Rate: 7.10% (2025-2033)

According to the latest report by IMARC Group, the Japan medical cannabis market size reached USD 2,188.2 million in 2024. Going forward, IMARC Group expects it to reach USD 4,070.6 million by 2033, exhibiting a CAGR of 7.10% from 2025 to 2033.

Japan Medical Cannabis Industry Trends and Drivers

The Japan medical cannabis market is witnessing notable growth, primarily due to the changing regulatory environment and acceptance of cannabis-based therapeutics. An important component continues to be an increase in consumer awareness and acceptance of the many non-psychoactive cannabidiol (CBD) products available for purchase. Consumer demand continues to increase as it becomes more known that CBD can help with stress and anxiety disorders, chronic pain, sleep disorder, and much more. Moreover, the growth of the medical cannabis market is an aging population that wants to further explore alternative therapies for treatment of arthritis, insomnia, and other conditions. A major contributor to growth is the gradual regulatory changes or legal reforms taking place recently - The Cannabis Control Law was amended, allowing for the development of CBD based pharmaceuticals and clinical trials, and while restrictive on THC, parallel processes are also in place for the development of THC products.

Advancements in research regarding therapeutic applications related to more severe health conditions such as epilepsy, sleep disorders, and cancer patients experiencing pain are also allowing for a gradual shift from social stigmas of the past to more scientific based inquiry, acceptance, and expectations. Finally, as e-commerce keeps evolving, and the retail landscape continues to evolve to include specialty retail, Canadian consumers can somewhat more freely access THC-free products such as CBD oil and capsules from either sector, or buy products online in a mostly hassle-free manner. All of these factors, and Japan's priority placed on health care innovation, are creating a perception of a promising outlook for the medical cannabis market.

Download a Sample PDF of This Report:  https://www.imarcgroup.com/japan-medical-cannabis-market/requestsample

Japan Medical Cannabis Market Segmentation

The market report offers a comprehensive analysis of the segments, highlighting those with the largest Japan medical cannabis market share. It includes forecasts for the period 2025-2033 and historical data from 2019-2024 for the following segments.

Species Insights:

• Indica
• Sativa
• Hybrid

Derivatives Insights:

• Cannabidiol (CBD)
• Tetrahydrocannabinol (THC)
• Others

Application Insights:

• Cancer
• Arthritis
• Migraine
• Epilepsy
• Others

Route of Administration Insights:

• Oral Solutions and Capsules
• Vaporizers
• Topicals
• Others

End Use Insights:

• Pharmaceutical Industry
• Research and Development Centres
• Others

Regional Insights:

• Kanto Region
• Kinki Region
• Central/Chubu Region
• Kyushu-Okinawa Region
• Tohoku Region
• Chugoku Region
• Hokkaido Region
• Shikoku Region

Request a Customized Report for Deeper Insights: https://www.imarcgroup.com/request?type=report&id=31920&flag=E 

Competitive Landscape

The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant. Additionally, the report features detailed profiles of all major companies in the Japan medical cannabis industry.

Key Highlights of the Report:

• Market Performance (2019-2024)
• Market Outlook (2025-2033)
• COVID-19 Impact on the Market
• Porter’s Five Forces Analysis
• Strategic Recommendations
• Historical, Current, and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact

Street: 563-13 Kamien
Area: Iwata
Country: Tokyo, Japan
Postal Code: 4380111
Email: sales@imarcgroup.com